C5 inhibition allows continued antineoplastic therapy in cancer- And chemotherapy-associated thrombotic microangiopathy

Hridaya Shah; Hang Chen; Xiang Zuo Pan; Ara Metjian; Robert A. Brodsky; Evan M. Braunstein; Shruti Chaturvedi

doi:10.1182/bloodadvances.2022008395

C5 inhibition allows continued antineoplastic therapy in cancer- And chemotherapy-associated thrombotic microangiopathy

Hridaya Shah, Hang Chen, Xiang Zuo Pan, Ara Metjian, Robert A. Brodsky, Evan M. Braunstein, Shruti Chaturvedi

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	6071-6074
Number of pages	4
Journal	Blood Advances
Volume	6
Issue number	23
DOIs	https://doi.org/10.1182/bloodadvances.2022008395
State	Published - Dec 13 2022

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2022008395

Cite this

@article{04e6cf88196b47d88ea20050e6aaaa48,

title = "C5 inhibition allows continued antineoplastic therapy in cancer- And chemotherapy-associated thrombotic microangiopathy",

author = "Hridaya Shah and Hang Chen and Pan, {Xiang Zuo} and Ara Metjian and Brodsky, {Robert A.} and Braunstein, {Evan M.} and Shruti Chaturvedi",

note = "Funding Information: Acknowledgment: This work was supported by National Institutes of Health, Heart, Lung and Blood Institute grant K99HL150594 (S.C.).",

year = "2022",

month = dec,

day = "13",

doi = "10.1182/bloodadvances.2022008395",

language = "English (US)",

volume = "6",

pages = "6071--6074",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "23",

}

TY - JOUR

T1 - C5 inhibition allows continued antineoplastic therapy in cancer- And chemotherapy-associated thrombotic microangiopathy

AU - Shah, Hridaya

AU - Chen, Hang

AU - Pan, Xiang Zuo

AU - Metjian, Ara

AU - Brodsky, Robert A.

AU - Braunstein, Evan M.

AU - Chaturvedi, Shruti

N1 - Funding Information: Acknowledgment: This work was supported by National Institutes of Health, Heart, Lung and Blood Institute grant K99HL150594 (S.C.).

PY - 2022/12/13

Y1 - 2022/12/13

UR - http://www.scopus.com/inward/record.url?scp=85144795073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144795073&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2022008395

DO - 10.1182/bloodadvances.2022008395

M3 - Article

C2 - 35914225

AN - SCOPUS:85144795073

SN - 2473-9529

VL - 6

SP - 6071

EP - 6074

JO - Blood advances

JF - Blood advances

IS - 23

ER -

C5 inhibition allows continued antineoplastic therapy in cancer- And chemotherapy-associated thrombotic microangiopathy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this